Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer
Clinical trial NCT06791460 · RECRUITING
Trial details
- NCT number
- NCT06791460
- Sponsor
- Obstetrics & Gynecology Hospital of Fudan University
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-18
- Primary completion
- 2028-02-14
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.